Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
106
NMPA:92
SFDA:14
Drug Approvals
Asciminib Hydrochloride Tablets
- Product Name
- 信倍立
- Approval Number
- 国药准字HJ20250056
- Approval Date
- May 13, 2025
NMPA
Deferasirox Dispersible Tablets
- Product Name
- 恩瑞格
- Approval Number
- 国药准字HJ20150208
- Approval Date
- Aug 22, 2024
NMPA
Capmatinib Hydrochloride Tablets
- Product Name
- 妥瑞达
- Approval Number
- 国药准字HJ20240041
- Approval Date
- Jun 11, 2024
NMPA
Capmatinib Hydrochloride Tablets
- Product Name
- 妥瑞达
- Approval Number
- 国药准字HJ20240042
- Approval Date
- Jun 11, 2024
NMPA
Iptacopan Hydrochloride Capsules
- Product Name
- 飞赫达
- Approval Number
- 国药准字HJ20240016
- Approval Date
- Apr 24, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 10
- Next
Clinical Trials
No trials found
News
No news found